Literature DB >> 16956949

Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.

Erik S Zimmerman1, Michael P Sherman, Jana L Blackett, Jason A Neidleman, Christophe Kreis, Pamela Mundt, Samuel A Williams, Maria Warmerdam, James Kahn, Frederick M Hecht, Robert M Grant, Carlos M C de Noronha, Andrew S Weyrich, Warner C Greene, Vicente Planelles.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) causes cell cycle arrest in G2. Vpr-expressing cells display the hallmarks of certain forms of DNA damage, specifically activation of the ataxia telangiectasia mutated and Rad3-related kinase, ATR. However, evidence that Vpr function is relevant in vivo or in the context of viral infection is still lacking. In the present study, we demonstrate that HIV-1 infection of primary, human CD4+ lymphocytes causes G2 arrest in a Vpr-dependent manner and that this response requires ATR, as shown by RNA interference. The event leading to ATR activation in CD4+ lymphocytes is the accumulation of replication protein A in nuclear foci, an indication that Vpr likely induces stalling of replication forks. Primary macrophages are refractory to ATR activation by Vpr, a finding that is consistent with the lack of detectable ATR, Rad17, and Chk1 protein expression in these nondividing cells. These observations begin to explain the remarkable resilience of macrophages to HIV-1-induced cytopathicity. To study the in vivo consequences of Vpr function, we isolated CD4+ lymphocytes from HIV-1-infected individuals and interrogated the cell cycle status of anti-p24Gag-immunoreactive cells. We report that infected cells in vivo display an aberrant cell cycle profile whereby a majority of cells have a 4N DNA content, consistent with the onset of G2 arrest.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956949      PMCID: PMC1641771          DOI: 10.1128/JVI.01212-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

2.  ATR disruption leads to chromosomal fragmentation and early embryonic lethality.

Authors:  E J Brown; D Baltimore
Journal:  Genes Dev       Date:  2000-02-15       Impact factor: 11.361

3.  Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.

Authors:  F Re; D Braaten; E K Franke; J Luban
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes.

Authors:  M R Elstad; T R La Pine; F S Cowley; R P McEver; T M McIntyre; S M Prescott; G A Zimmerman
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

Review 5.  Effect of HIV-1 Vpr on cell cycle regulators.

Authors:  Shohreh Amini; Kamel Khalili; Bassel E Sawaya
Journal:  DNA Cell Biol       Date:  2004-04       Impact factor: 3.311

6.  The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection.

Authors:  M E Rogel; L I Wu; M Emerman
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

8.  The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle.

Authors:  J B Jowett; V Planelles; B Poon; N P Shah; M L Chen; I S Chen
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.

Authors:  R I Connor; B K Chen; S Choe; N R Landau
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

10.  Viral dynamics in human immunodeficiency virus type 1 infection.

Authors:  X Wei; S K Ghosh; M E Taylor; V A Johnson; E A Emini; P Deutsch; J D Lifson; S Bonhoeffer; M A Nowak; B H Hahn
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

View more
  67 in total

1.  Critical role for antiapoptotic Bcl-xL and Mcl-1 in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-Vpr-induced apoptosis.

Authors:  Aurelia Busca; Mansi Saxena; Ashok Kumar
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

Review 2.  New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder.

Authors:  Min Cui; Yunlong Huang; Yong Zhao; Jialin Zheng
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

3.  Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.

Authors:  Tram N Q Pham; Jonathan Richard; Francine C A Gerard; Christopher Power; Éric A Cohen
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  Ex vivo analysis of SIV-infected cells by flow cytometry.

Authors:  Matthew R Reynolds; Shari M Piaskowski; Kimberly L Weisgrau; Andrea M Weiler; Thomas C Friedrich; Eva G Rakasz
Journal:  Cytometry A       Date:  2010-11       Impact factor: 4.355

5.  Potential of Radiation-Induced Cellular Stress for Reactivation of Latent HIV-1 and Killing of Infected Cells.

Authors:  Sergey Iordanskiy; Fatah Kashanchi
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02       Impact factor: 2.205

6.  Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors.

Authors:  Zhihong Wan; Ning Zhi; Susan Wong; Keyvan Keyvanfar; Delong Liu; Nalini Raghavachari; Peter J Munson; Su Su; Daniela Malide; Sachiko Kajigaya; Neal S Young
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

Review 7.  Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation.

Authors:  Jason L Dehart; Vicente Planelles
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 8.  Viral manipulation of DNA repair and cell cycle checkpoints.

Authors:  Mira S Chaurushiya; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2009-05-26

9.  HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.

Authors:  Jonathan Richard; Sardar Sindhu; Tram N Q Pham; Jean-Philippe Belzile; Eric A Cohen
Journal:  Blood       Date:  2009-12-14       Impact factor: 22.113

10.  Ataxia telangiectasia-mutated-Rad3-related DNA damage checkpoint signaling pathway triggered by hepatitis B virus infection.

Authors:  Fan Zhao; Ning-Bo Hou; Xiao-Li Yang; Xiang He; Yu Liu; Yan-Hong Zhang; Cong-Wen Wei; Ting Song; Li Li; Qing-Jun Ma; Hui Zhong
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.